143.94
Precedente Chiudi:
$148.30
Aprire:
$147.19
Volume 24 ore:
1.26M
Relative Volume:
0.82
Capitalizzazione di mercato:
$20.05B
Reddito:
$1.53B
Utile/perdita netta:
$-214.69M
Rapporto P/E:
-81.78
EPS:
-1.76
Flusso di cassa netto:
$-43.68M
1 W Prestazione:
-4.77%
1M Prestazione:
-8.09%
6M Prestazione:
+14.49%
1 anno Prestazione:
+57.38%
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NTRA
Natera Inc
|
143.94 | 20.05B | 1.53B | -214.69M | -43.68M | -1.76 |
![]()
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
![]()
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
2025-01-23 | Iniziato | Barclays | Overweight |
2024-06-03 | Ripresa | Jefferies | Buy |
2024-04-08 | Ripresa | Craig Hallum | Buy |
2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
2023-12-29 | Reiterato | BTIG Research | Buy |
2023-12-14 | Iniziato | Guggenheim | Buy |
2023-12-13 | Iniziato | Wolfe Research | Outperform |
2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2023-09-28 | Iniziato | Bernstein | Mkt Perform |
2023-07-05 | Ripresa | JP Morgan | Overweight |
2023-05-05 | Iniziato | UBS | Buy |
2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-04-25 | Iniziato | Stephens | Overweight |
2022-03-08 | Iniziato | Goldman | Buy |
2022-01-06 | Ripresa | Piper Sandler | Overweight |
2021-10-15 | Ripresa | Cowen | Outperform |
2021-06-15 | Iniziato | Raymond James | Mkt Perform |
2021-05-25 | Iniziato | Wells Fargo | Overweight |
2021-01-28 | Iniziato | Truist | Buy |
2020-10-08 | Iniziato | BTIG Research | Buy |
2020-09-28 | Iniziato | Morgan Stanley | Overweight |
2020-09-17 | Iniziato | SVB Leerink | Outperform |
2020-06-10 | Ripresa | Piper Sandler | Overweight |
2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
2018-10-05 | Iniziato | JP Morgan | Neutral |
2018-07-05 | Reiterato | Piper Jaffray | Overweight |
2017-08-07 | Reiterato | Morgan Stanley | Overweight |
2016-11-10 | Reiterato | The Benchmark Company | Buy |
2016-05-23 | Reiterato | The Benchmark Company | Buy |
2016-05-11 | Reiterato | The Benchmark Company | Buy |
2016-04-19 | Iniziato | The Benchmark Company | Buy |
2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2015-08-04 | Iniziato | Robert W. Baird | Outperform |
2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
2015-07-27 | Iniziato | Piper Jaffray | Overweight |
2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Game-Changing Heart Transplant Monitoring Trial Results: 1,100+ Patient Study Could Transform Post-Surgery Care - StockTitan
Natera’s Busy 2025 Continues - The Healthcare Technology Report.
(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate
Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey
Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law
12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa
Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN
Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance
Natera’s chief legal officer sells $135,521 in stock By Investing.com - Investing.com Canada
Natera president sells $149,835 in stock By Investing.com - Investing.com Canada
Natera’s executive chairman sells $164,583 in stock By Investing.com - Investing.com Canada
Natera CEO Chapman sells $978,677 in company stock By Investing.com - Investing.com South Africa
Natera co-founder Sheena Jonathan sells $856,410 in stock By Investing.com - Investing.com South Africa
Natera president sells $149,835 in stock - Investing.com India
Natera’s chief legal officer sells $135,521 in stock - Investing.com India
Natera Executives and Directors Sell Shares to Cover Tax Obligations - TradingView
Natera CFO Michael Burkes sells $115,661 in company stock - Investing.com
Natera CEO Chapman sells $978,677 in company stock - Investing.com
Natera’s president John Fesko sells $116,099 in stock - Investing.com
Natera co-founder Sheena Jonathan sells $856,410 in stock - Investing.com India
Natera’s executive chairman sells $164,583 in stock - Investing.com India
Is Natera (NTRA) the Best Biotech Stock According to Billionaires? - Yahoo Finance
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Is Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires? - Insider Monkey
Natera: Strong Growth Trajectory Despite Stretched Valuation Metrics (NASDAQ:NTRA) - Seeking Alpha
Natera Inc.: Strong Execution in Revenue Per Test Powering Our Optimism! - Smartkarma
Natera: Solid Execution, Pricey Stock (NASDAQ:NTRA) - Seeking Alpha
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time - Seeking Alpha
Natera Inc (NTRA) Stock Price Up 4.01% on Mar 17 - GuruFocus.com
Natera initiated with an Outperform at RBC Capital - MSN
Natera Sees Unusually Large Options Volume (NASDAQ:NTRA) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NTRA - Business Wire
RBC Capital initiates Exact Sciences with Sector Perform, Natera with Outperform - MSN
INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA - Business Wire
Natera director Marcus Gail Boxer sells $590,773 in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells $7.39 million in stock By Investing.com - Investing.com Canada
Natera director Marcus Gail Boxer sells $590,773 in stock - Investing.com India
Natera executive chairman sells $7.39 million in stock - Investing.com
Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation - Nasdaq
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board - Simply Wall St
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):